20 "Past Their Prime" Stocks to Dump From Your Portfolio - 20 of 20 Slide 20Back to 19Next Slideshow Back to 19Next Slideshow Immunovant (NASDAQ:IMVT)Immunovant, Inc, a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that target the neonatal fragment crystallizable receptor for the treatment of myasthenia gravis, thyroid eye disease, chronic inflammatory demyelinating polyneuropathy, and Graves diseases, as well as warm autoimmune hemolytic anemia. More about Immunovant Trailing Twelve Months EPS: ($2.74)2025 EPS Estimate: ($2.69)2026 EPS Estimate: ($3.08)Current Stock Price $15.86Consensus Rating Moderate BuyRatings Breakdown 8 Buy Ratings, 2 Hold Ratings, 0 Sell Ratings.Consensus Price Target $38.33 (141.7% Upside)More Investing Slideshows:7 Cybersecurity Investments to Protect Your Portfolio, Your Data7 Dividend Kings That Offer Certainty Amid Market Chaos7 Small Caps Poised for Big Gains in 2025Donald Trump Owns These 7 Stocks, Should You?7 Stocks Changing the World—and Making Investors Wealthy7 High-Yield Dividend Stocks Under $50Quantum Leap: 7 Computing Stocks to Catapult Your Portfolio7 International Stocks to Buy as MAGA Reshapes the Market7 High-Growth Stocks Under $107 Food Stocks to Own for Under $20Slide 20Back to 19Next Slideshow More From MarketBeatTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored7 Stocks on Track for Dividend Increases in First Half of 2025 In relative terms, dividend stocks have underperformed the market. For example, the SPDR Portfolio S&P 5...MarketBeatAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored7 Dividend Kings That Offer Certainty Amid Market Chaos Dividend Kings refer to an exclusive group of companies that have increased the payment on their dividend fo...MarketBeatTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe 7 Best Electric Vehicle Stocks That Aren't TeslaWe all know that electric vehicles are the future of day-to-day transportation. They are simpler to manufactur...MarketBeat Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Slide 20Back to 19Next Slideshow Back to 19Next Slideshow Immunovant (NASDAQ:IMVT)Immunovant, Inc, a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that target the neonatal fragment crystallizable receptor for the treatment of myasthenia gravis, thyroid eye disease, chronic inflammatory demyelinating polyneuropathy, and Graves diseases, as well as warm autoimmune hemolytic anemia. More about Immunovant Trailing Twelve Months EPS: ($2.74)2025 EPS Estimate: ($2.69)2026 EPS Estimate: ($3.08)Current Stock Price $15.86Consensus Rating Moderate BuyRatings Breakdown 8 Buy Ratings, 2 Hold Ratings, 0 Sell Ratings.Consensus Price Target $38.33 (141.7% Upside)More Investing Slideshows:7 Cybersecurity Investments to Protect Your Portfolio, Your Data7 Dividend Kings That Offer Certainty Amid Market Chaos7 Small Caps Poised for Big Gains in 2025Donald Trump Owns These 7 Stocks, Should You?7 Stocks Changing the World—and Making Investors Wealthy7 High-Yield Dividend Stocks Under $50Quantum Leap: 7 Computing Stocks to Catapult Your Portfolio7 International Stocks to Buy as MAGA Reshapes the Market7 High-Growth Stocks Under $107 Food Stocks to Own for Under $20Slide 20Back to 19Next Slideshow More From MarketBeatTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored7 Stocks on Track for Dividend Increases in First Half of 2025 In relative terms, dividend stocks have underperformed the market. For example, the SPDR Portfolio S&P 5...MarketBeatAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored7 Dividend Kings That Offer Certainty Amid Market Chaos Dividend Kings refer to an exclusive group of companies that have increased the payment on their dividend fo...MarketBeatTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe 7 Best Electric Vehicle Stocks That Aren't TeslaWe all know that electric vehicles are the future of day-to-day transportation. They are simpler to manufactur...MarketBeat
